))
The Logistics of Cell & Gene Therapy – From Benchmarking to Standardization (Part 1)
Manage episode 418077912 series 3554424
Sisällön tarjoaa Quick Group of Companies. Quick Group of Companies tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Medical care and scientific research offer some of the most challenging – and developing – areas for global supply chain logistics. And few are more significant– in terms of potential for improving human life and logistics precision required – than Cell & Gene Therapy or CGT.
These CGT “medical miracles” bring logistics opportunities and challenges, around timing, temperature, chain of identity, synchronization, integration, scale, back up planning, and more.
So, what is required – logistically – to help ensure CGT clinical trials and personalized therapies get handled safely, securely, and on time?
QuickSTAT's Global Head of Strategy for CGT and DTP, Mike Sweeney and Senior VP of Commercial Operations Scott Ohanesian explain.
For more information on clinical trial logistics, visit our website at quickstat.com.
8 jaksoa
Jaa
